Workenhe ST - Search Results

1

LAMP3/CD63 Expression in Early and Late Endosomes in Human Vaginal Epithelial Cells Is Associated with Enhancement of HSV-2 Infection.

Nazli A, Chow R, Zahoor MA, Workenhe ST, Dhawan T, Verschoor C, Kaushic C. Nazli A, et al. Among authors: workenhe st. J Virol. 2022 Dec 14;96(23):e0155322. doi: 10.1128/jvi.01553-22. Epub 2022 Nov 9. J Virol. 2022. PMID: 36350153 Free PMC article.

2

Countermeasures against viral diseases of farmed fish.

Kibenge FS, Godoy MG, Fast M, Workenhe S, Kibenge MJ. Kibenge FS, et al. Antiviral Res. 2012 Sep;95(3):257-81. doi: 10.1016/j.antiviral.2012.06.003. Epub 2012 Jun 18. Antiviral Res. 2012. PMID: 22721634 Review.

3

Structural and functional studies of an IRF-7-like gene from Atlantic salmon.

Kileng O, Bergan V, Workenhe ST, Robertsen B. Kileng O, et al. Among authors: workenhe st. Dev Comp Immunol. 2009;33(1):18-27. doi: 10.1016/j.dci.2008.07.020. Dev Comp Immunol. 2009. PMID: 18778729

4

TRIM26 Facilitates HSV-2 Infection by Downregulating Antiviral Responses through the IRF3 Pathway.

Dhawan T, Zahoor MA, Heryani N, Workenhe ST, Nazli A, Kaushic C. Dhawan T, et al. Among authors: workenhe st. Viruses. 2021 Jan 6;13(1):70. doi: 10.3390/v13010070. Viruses. 2021. PMID: 33419081 Free PMC article.

5

Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.

Workenhe ST, Simmons G, Pol JG, Lichty BD, Halford WP, Mossman KL. Workenhe ST, et al. Mol Ther. 2014 Jan;22(1):123-31. doi: 10.1038/mt.2013.238. Epub 2013 Oct 9. Mol Ther. 2014. PMID: 24343053 Free PMC article.

6

Viral-mediated activation and inhibition of programmed cell death.

Verburg SG, Lelievre RM, Westerveld MJ, Inkol JM, Sun YL, Workenhe ST. Verburg SG, et al. Among authors: workenhe st. PLoS Pathog. 2022 Aug 11;18(8):e1010718. doi: 10.1371/journal.ppat.1010718. eCollection 2022 Aug. PLoS Pathog. 2022. PMID: 35951530 Free PMC article. Review.

7

Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.

Workenhe ST, Pol JG, Lichty BD, Cummings DT, Mossman KL. Workenhe ST, et al. Cancer Immunol Res. 2013 Nov;1(5):309-19. doi: 10.1158/2326-6066.CIR-13-0059-T. Epub 2013 Aug 19. Cancer Immunol Res. 2013. PMID: 24777969

8

Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.

Workenhe ST, Ketela T, Moffat J, Cuddington BP, Mossman KL. Workenhe ST, et al. Oncogene. 2016 May 12;35(19):2465-74. doi: 10.1038/onc.2015.303. Epub 2015 Aug 10. Oncogene. 2016. PMID: 26257065

9

Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.

Zakaria C, Sean P, Hoang HD, Leroux LP, Watson M, Workenhe ST, Hearnden J, Pearl D, Truong VT, Robichaud N, Yanagiya A, Tahmasebi S, Jafarnejad SM, Jia JJ, Pelin A, Diallo JS, Le Boeuf F, Bell JC, Mossman KL, Graber TE, Jaramillo M, Sonenberg N, Alain T. Zakaria C, et al. Among authors: workenhe st. PLoS Pathog. 2018 Aug 23;14(8):e1007264. doi: 10.1371/journal.ppat.1007264. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30138450 Free PMC article.

10

Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1.

Hoang HD, Said A, Vaidya N, Gilchrist VH, Malone K, Kabilan U, Topshee S, Xiang X, Yang AD, Olagnier D, Mossman K, Beug ST, Jafarnejad SM, Workenhe ST, Graber TE, Alain T. Hoang HD, et al. Among authors: workenhe st. J Immunother Cancer. 2023 Mar;11(3):e006408. doi: 10.1136/jitc-2022-006408. J Immunother Cancer. 2023. PMID: 36958764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page